The 340B program is confusing. That’s a fact that likely no one would question. In fact, it is often forgotten in broader discussions about our health care system even though it is the second largest federal prescription drug program. That’s a problem considering the ever-growing evidence that 340B isn’t working in the best interests of patients. If 340B worked as Congress intended, it could serve as a vital safety net for needy patients – but that isn’t the case today.
